Sign In
Buy TMDX
$76.51
+0.380 (+0.499%)
At Close: Jul 31, 2026
TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Wednesday, 22'nd Oct 2025
TransMedics (TMDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TransMedics Group (TMDX) to Release Quarterly Earnings on Wednesday
03:00am, Wednesday, 22'nd Oct 2025
TransMedics Group (NASDAQ: TMDX - Get Free Report) is projected to issue its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect the company to announce earnings of $0.
TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025
04:05pm, Wednesday, 15'th Oct 2025
ANDOVER, Mass. , Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade
09:37am, Wednesday, 08'th Oct 2025
One great thing about the healthcare sector is that the need for medical services never goes out of style, and in fact, is likely to be in even higher demand in the next decade.
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
01:56pm, Thursday, 25'th Sep 2025
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
Here's Why TransMedics (TMDX) is a Strong Growth Stock
10:46am, Wednesday, 24'th Sep 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TransMedics: I'm More Bullish Than Ever
09:40am, Monday, 22'nd Sep 2025
TransMedics remains a strong buy despite recent pullback, driven by seasonal weakness and changing transplant transport trends. TMDX's next-gen OCS heart and lung devices, along with kidney perfusion
Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy to support utilization of TransMedics' Organ Care System ("OCS") perfusion techn
Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 19'th Sep 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TransMedics: Upcoming Trials Are Critical
04:23pm, Tuesday, 16'th Sep 2025
Concerns about seasonal weakness have dragged TransMedics' share price lower in recent weeks. While TransMedics' growth is moderating, there remains a sizeable growth opportunity within just the U.S.
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term
06:01pm, Monday, 08'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
12:47pm, Monday, 08'th Sep 2025
TransMedics Group, Inc. (NASDAQ:TMDX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT Company Participants Waleed Hassanein - Founder, President, CEO & Director
TransMedics: Just Like The CEO, I'm Buying
10:53am, Wednesday, 03'rd Sep 2025
TransMedics remains a Strong Buy after stellar growth, innovative technology, and founder-led leadership, with shares up 88% YTD, far outpacing the S&P 500. The company's unique OCS platform, integrat
Reasons to Retain TransMedics Stock in Your Portfolio for Now
01:25pm, Friday, 29'th Aug 2025
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report?
12:36pm, Friday, 29'th Aug 2025
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
